FindTrial
Sign In

Heparin in the treatment of ulcerative colitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN31531671
Enrollment
Unknown
Registered
2003-09-12
Start date
1997-07-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System: Ulcerative colitis Digestive System Ulcerative colitis

Interventions

Intravenous heparin vs placebo

Sponsors

Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with known acute, moderate/severe ulcerative colitis, with a Powell-Tuck score =12 on relapse, requiring inpatient treatment with intravenous steroids

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Time to remission and time to next relapse.—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026